DEAL FLASH: PanTera, a Belgian radioisotope producer, has completed a US$104.1 million (€93 million) oversubscribed Series A fundraising round led ...
Read articleDEAL FLASH: PanTera, a Belgian radioisotope producer, has completed a US$104.1 million (€93 million) oversubscribed Series A fundraising round led ...
Read articleQUARTERLY M&A ACTIVITY: From securing growth capital to finding future partners, Oaklins' Q3 deals reflect strategic navigation in dynamic industry...
Read articleDEAL FLASH: AMC Media Group, a healthcare professional (HCP) community platform that enables medical associations and key opinion leaders (KOLs) to...
Read articleQUARTERLY M&A ACTIVITY: The second quarter of 2024 marked a dynamic period for Oaklins with 62 closed transactions. This activity underscores the a...
Read articleQUARTERLY M&A ACTIVITY: Q1 saw a dynamic market with significant M&A activity in various industries, with TMT leading with 15 deals. Energy, Real E...
Read articleQUARTERLY M&A ACTIVITY: Oaklins has proven its adaptability and strategic acumen in a challenging market, completing 87 transactions in Q4 and clim...
Read articleJULY & AUGUST | M&A ACTIVITY: We successfully executed 38 transactions, of which the majority were sell-side. Notably, over 75% of the transactions...
Read articleDEAL ACTIVITY | MAY: Amidst challenging market conditions, Oaklins sees M&A as a vital corporate strategy to build resilience and outperform compet...
Read articleDEAL FLASH: Oaklins’ team in the Netherlands acted as the exclusive M&A sell-side advisor to the shareholders of DierenDokters. This transaction em...
Read articleFEBRUARY DEAL ACTIVITY: Our activity followed a similar pace to what we saw in the first month of 2023 with 14 transactions closed, of which 13 wer...
Read articleJANUARY DEAL ACTIVITY: As we look to build on our 35+-year track record of helping clients navigate complex market conditions, January 2023 saw us ...
Read articleDEAL FLASH: The acquisition of MBI Healthcare Technologies by DNV AS demonstrates Oaklins’ ability to advise on complex international transactions ...
Read articleExplore our recent deals.
Read articleMONTHLY DEAL ACTIVITY: The ongoing economic turmoil is impacting M&A markets but the appetite for M&A persists with 37 transactions closed in July ...
Read articleDEAL FLASH: The acquisition of Silverlink PCS Software Limited provides Alcidion Group Limited with a PAS capability, which is the foundational dat...
Read articleMONTHLY DEAL ACTIVITY: 2022 has got off to a good start for Oaklins with 36 closed transactions of which 34 were M&A deals and two were fundraising...
Read articleDEAL FLASH: Ace Pharmaceuticals (Ace) has been acquired by a consortium of Gilde Buy Out Partners, Gilde Healthcare, Quadrum Capital and Ace’s mana...
Read articleTo gain resilience in times of change and transition, one of the most important things is to surround ourselves with knowledgeable and supportive p...
Read articleDEAL FLASH: Oaklins’ team in Lithuania acted as the sole sell-side financial advisor to CGP Management in the sale of MediCA klinika and Kardiolita...
Read articleDEAL FLASH: Millbrook Healthcare, a leading provider of healthcare-related services, has been acquired by Cairngorm Capital, a specialist private i...
Read articleDEAL FLASH: MJH Associates, Inc. has acquired major market media assets from the UBM Life Sciences Group of Informa PLC. This acquisition creates t...
Read articleDEAL FLASH: Oaklins’ team in Italy has advised Lifco AB, a Swedish investment group, on the acquisition of a majority stake in Rhein83 Srl. Lifco a...
Read articleDEAL FLASH: Oaklins’ team in Germany has advised the private shareholders of Acutronic Group, a group on non-affiliated companies active in neonata...
Read articleDEAL FLASH: Oaklins’ team in Germany and our healthcare specialist in New York have advised the shareholders of Vascotube GmbH, a global manufactur...
Read article